Johnson & Johnson Sees $9.18M in Unusual Options Activity Despite 2.18% Stock Decline
By TrendSpider Editor
Johnson & Johnson attracted over $9.18 million in total options premium on Wednesday, November 18, 2026, with bullish call activity dominating the flow even as shares fell 2.18% to $272.75. Two deep in-the-money call contracts accounted for the overwhelming majority of that premium, signaling that s
Johnson & Johnson Sees $9.18M in Unusual Options Activity Despite 2.18% Stock Decline
Johnson & Johnson attracted over $9.18 million in total options premium on Wednesday, November 18, 2026, with bullish call activity dominating the flow even as shares fell 2.18% to $272.75. Two deep in-the-money call contracts accounted for the overwhelming majority of that premium, signaling that sophisticated traders may be positioning for a longer-term recovery. With the stock trading near the upper half of its 52-week range of $195.90 to $290.25, the options flow arrives at a technically meaningful level.
Key Drivers of the JNJ Stock Move
- Main Catalyst: Three unusual options contracts were flagged today totaling $9,184,213 in premium. Two large in-the-money call positions, one at the $190 strike expiring June 17, 2027 with a size of 514 contracts, and another at the $185 strike expiring January 15, 2027 with a size of 528 contracts, drove the bulk of the activity. A smaller put at the $265 strike expiring December 31, 2026 rounded out the flow with just 50 contracts and $29,500 in premium.
- Bull Case: The two call contracts combined for $9,154,713 in premium, representing the clear directional lean of today's unusual flow. Both are deep in the money, suggesting strong conviction in continued upside or at minimum a hedge against a large existing short position. The $185 call alone generated $4,701,299 in premium at a 16% open interest ratio, while the $190 call generated $4,453,414 at a 33% open interest ratio.
- Bear Case: The stock fell 2.18% on the session, and the $265 put expiring December 31, 2026 showed an open interest ratio of 238%, meaning volume today was more than double the existing open interest, the highest relative activity of any contract in today's flow. Though small in dollar terms, that outsized OI ratio suggests a targeted near-term downside bet heading into year-end.
The forward setup for JNJ carries a degree of tension between the bullish long-dated call positioning and the near-term stock weakness. The $265 put with a December 31 expiry indicates at least some traders are bracing for further downside before the end of the calendar year, while the January and June call buyers appear comfortable holding exposure well into 2027. At $272.75, JNJ sits roughly $17.50 below its 52-week high of $290.25, leaving meaningful room to run if momentum reverses. Traders will want to watch how price interacts with the $265 level, which now carries notable options interest, as a potential near-term support or breakdown zone heading into the final weeks of 2026.
JNJ Unusual Options Activity
- Contract 1: Call | Strike: $190 | Expiry: June 17, 2027 | Volume: 514 | Open Interest Ratio: 33% | ITM | Premium: $4,453,414
- Contract 2: Call | Strike: $185 | Expiry: January 15, 2027 | Volume: 528 | Open Interest Ratio: 16% | ITM | Premium: $4,701,299
- Contract 3: Put | Strike: $265 | Expiry: December 31, 2026 | Volume: 50 | Open Interest Ratio: 238% | OTM | Premium: $29,500
JNJ Seasonality
Mid-to-late November historically marks a transitional period for large-cap healthcare names as institutional investors rebalance ahead of year-end. The concentration of call activity in January and June expirations suggests buyers are looking past any near-term seasonal volatility and positioning for performance in early-to-mid 2027.
JNJ Relative Performance
JNJ's 2.18% decline on Wednesday puts pressure on the stock's positioning within the broader healthcare sector. At $272.75, shares remain well above the 52-week low of $195.90, but the session's pullback represents a notable step back from the $290.25 annual high reached earlier in the year. Relative underperformance on a down day of this magnitude could attract attention from sector-focused traders watching large-cap healthcare for signs of rotation.
More on JNJ
- Johnson & Johnson Sees Heavy Put Activity as $2.68M Bet Targets Near-Term Downside
- Johnson & Johnson Inches Toward 52-Week High as Stock Consolidates Near $288
- Johnson & Johnson Stock Pushes to 52-Week High Territory as Shares Approach $286.07 Peak
- Johnson & Johnson Trades Just Above 52-Week High as Stock Holds Near $283.50
- Johnson & Johnson Hovers Just Below Its 52-Week High of $283.25 Despite Modest Dip
Latest Market News
- Palo Alto Networks Drops 7.94% Despite 20 Analyst Confirmations and $432 Average Price Target
- Meta Platforms Drops Nearly 6% as Shares Slide Toward 52-Week Low Territory
- Oracle Stock Craters 6.4%, Breaking Below Its 52-Week Low to $103.44
- QUALCOMM Shares Plunge 7.41% to $150.01, Nearing 52-Week Lows
- CrowdStrike Shares Crater 15% on Friday, Erasing Months of Gains in a Single Session
- Snowflake Shares Tumble 5.13% as Stock Retreats Sharply from Recent Highs